Literature DB >> 17725609

Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.

O Senturk1, O Kocaman, S Hulagu, T Sahin, C Aygun, T Konduk, A Celebi.   

Abstract

BACKGROUND: The components of the metabolic syndrome are closely related with endothelial dysfunction, which is a pathophysiological issue of cardiovascular diseases. Non-alcoholic fatty liver disease (NAFLD) is considered as one of the components of the metabolic syndrome. The aim of this study was to evaluate the endothelial-dependent dilatation (EDD) and endothelial-independent dilatation (EID) of the brachial artery in NAFLD.
METHODS: Fifteen non-alcoholic steatohepatitis (NASH), 17 patients with simple steatosis and 16 healthy subjects formed the study group. Non-alcoholic fatty liver disease group was composed of patients admitted to the gastroenterology outpatient clinic because of increased liver enzymes. Endothelial functions of the brachial artery were evaluated by vascular ultrasound. EDD was assessed by establishing reactive hyperaemia, and EID was determined by using sublingual nitrate.
RESULTS: No statistical difference for the basal diameter of brachial artery was found between the groups (P = 0.49). The values for EDD and EID were significantly different across all three groups (P < 0.0001 and P < 0.0001, respectively). EDD and EID were significantly lower in NASH compared with simple steatosis (P = 0.01 and P < 0.01, respectively). However, there was no statistical significance for EDD and EID in simple steatosis groups compared with controls (P = 0.58 and P = 0.98, respectively).
CONCLUSIONS: Our study showed that patients with NASH had significantly worse endothelial dysfunction compared with patients with simple steatosis and healthy subjects. The treatment strategies with ameliorative effects for endothelial dysfunction might be effective for delaying the development of cardiovascular complications in NAFLD.

Entities:  

Mesh:

Year:  2007        PMID: 17725609     DOI: 10.1111/j.1445-5994.2007.01481.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  16 in total

1.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease.

Authors:  Yasar Colak; Ebubekir Senates; Atakan Yesil; Yusuf Yilmaz; Oguzhan Ozturk; Levent Doganay; Ender Coskunpinar; Ozlem Timirci Kahraman; Banu Mesci; Celal Ulasoglu; Ilyas Tuncer
Journal:  Endocrine       Date:  2012-06-03       Impact factor: 3.633

2.  Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.

Authors:  Michelle T Long; Na Wang; Martin G Larson; Gary F Mitchell; Joseph Palmisano; Ramachandran S Vasan; Udo Hoffmann; Elizabeth K Speliotes; Joseph A Vita; Emelia J Benjamin; Caroline S Fox; Naomi M Hamburg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

Review 3.  Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

Authors:  Eda Kaya; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 4.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  Nonalcoholic fatty liver disease and cardiovascular risk.

Authors:  Vijay Laxmi Misra; Mouen Khashab; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2009-02

6.  Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.

Authors:  Chia-Hung Chiang; Po-Hsun Huang; Fa-Po Chung; Zu-Yin Chen; Hsin-Bang Leu; Chin-Chou Huang; Tao-Cheng Wu; Jaw-Wen Chen; Shing-Jong Lin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease.

Authors:  Muyesser Sayki Arslan; Sibel Turhan; Irem Dincer; Dilsa Mizrak; Demet Corapcioglu; Ramazan Idilman
Journal:  Diabetol Metab Syndr       Date:  2014-10-14       Impact factor: 3.320

8.  LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.

Authors:  Kento Imajo; Hideyuki Hyogo; Masato Yoneda; Yasushi Honda; Takaomi Kessoku; Wataru Tomeno; Yuji Ogawa; Masataka Taguri; Hironori Mawatari; Yuichi Nozaki; Koji Fujita; Hiroyuki Kirikoshi; Satoru Saito; Yoshio Sumida; Masafumi Ono; Koichiro Wada; Atsushi Nakajima; Yuichiro Eguchi
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

9.  Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD.

Authors:  Ferdane Sapmaz; Metin Uzman; Sebahat Basyigit; Selcuk Ozkan; Bunyamin Yavuz; Abdullah Yeniova; Ayse Kefeli; Zeliha Asilturk; Yasar Nazligül
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

10.  Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease.

Authors:  Teoman Dogru; Erdim Sertoglu; Gurkan Celebi; Hasan Gurel; Cemal Nuri Ercin
Journal:  Ups J Med Sci       Date:  2013-12-13       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.